On this page of Benford's Law Stocks.com we present our study of Oncocyte Corp — ticker symbol OCX. SEC filings have been screened by our Benford's Law software, for quarterly 10Q and annual 10K filings from 4/15/2024 to 5/12/2025 for Oncocyte Corp under CIK number 0001642380. For filings made in XBRL (eXtensible Business Reporting Language) format, our algorithm extracts all "tagged" numbers presented by the company; for any non-XBRL filings our algorithm uses its own interal set of rules to extract what it believes to be numbers as found throughout the filings. The format found for each filing is presented below together with the results for OCX, with the percentage of found numbers beginning with each digit (1's, 2's, 3's, 4's, 5's, 6's, 7's, 8's, and 9's) charted against the "normal" range observed throughout our coverage universe, as well as the "normal" range for Oncocyte Corp based on the past OCX filings our system processed in the past.
28.3
20.5
15.8
8.6
5.8
5.5
4.8
3.9
6.8
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
XBRL?   [ original filing, OCX stockholder letter ]
Total numbers found: 689
Recent share count: 28,599,285 (2's column)

= Typical range across full coverage universe
Benford's Law Stocks Indicator
689
Normal count compared to other filers, falling within the middle 50%. At this number count, it would take about 7 numbers to move any given column by a full percentage point.
73

Starting from a possible score of 100, we made the following score deductions:
 • We deducted point upon observing the 2's percentage was above the typical coverage universe range.
 • We deducted points upon observing the 3's percentage was above the typical coverage universe range.
 • We deducted points upon observing the 3's percentage was above the company's typical historical range.
 • We deducted point upon observing the 5's percentage was below the typical coverage universe range.
 • We deducted points upon observing the 5's percentage was below the company's typical historical range.
 • The 9's percentage was higher than the 8's percentage, increasing the penalty multiplier.
 • We deducted points (includes the impact of penalty multiplier) upon observing the 9's percentage was above the typical coverage universe range.
 • We deducted points (includes the impact of penalty multiplier) upon observing the 9's percentage was above the company's typical historical range.
Benford's Law Stocks Indicator
OCX
Normal-to-low score compared to other filers, falling within the bottom of the middle 50%.
LRMR
MPAA
PDEX
PMD
MBIO
NCNO
OTTR
PLCE
Check our work! We provide our Oncocyte Corp Benford's Law analysis for informational purposes only, and our software should be expected to make mistakes and contain errors (nothing you see on this website should be relied upon for any decision-making without first repeating the analysis yourself independently), and so below we present to you all of the numbers our system detected, for the OCX filing above. This way, you can open the filing on your own and compare what you see below against what you yourself find. This can also be helpful for exploring any columns in particular that caught your eye.

1's 2's 3's
We found 195 numbers that start with the digit 1. Here they are:
16
1,613
1,235
11,759
14,600
14,607
1,700
1,700
1,939
1,116
1,116
1,927
1,404
1,295
17,453
10,218
12,274
176
109
1,325
1,206
169
15
157
153
128
138
1.13
17,453
12,274
14
14
11,146
10,218
10
10
12
11,588
14
169
1,927
1,027
10,336
11,132
1,067
123
10.2
1,366,364
169,000
154
176
1.6
16,000
100
12
100
100
100
12
100
12
100
100
17
14
14
1.1
1.13
1,106
1,298
1,500
1,340
1,830
1,500
1,210
11,130
13.2
13.4
16.2
1,980
10
13.2
13.5
10
14.6
15.6
10
19.5
11.7
11,700
11,700
15,040
15,040
14,600
14,607
1.7
1.3
1.5
1.3
150,000
1.7
1.7
13,400
13,400
101,987
10,681
1,642
1,789
1,466
1,713
1,434
1,673
10.47
10.44
10.23
1,182
1,023
138,000
114,000
173,000
110,000
11,765
1,000
10,000,000
15
1,064
1.1
118,000
17,452,824
15.8
1.7
10.2
109,756
12,000
109.20
109.20
12,467
16,217
1,026,314
1,091
12.42
100
1.73
1,106
12.14
138
1,106
12.14
138
1,611
103.71
105.0
1.65
120,000
1.09
1.74
156,000
100,000
1.43
173,000
195
167
150,093
143,292
1,341,381
150,001
1,200,109
100,000
10.2
1,315,339
100,000
109,756
10,590,000
1,253,134
10,500,000
150,000
1,463,414
12,195
1.1
1.5
154
176
1,280
1,165
1,104
158
169
15
157
153
109
176
1,393
143
170
We found 141 numbers that start with the digit 2. Here they are:
28,599,285
279
2,589
2,757
2,279
2,279
2,524
228
2,074
2,369
230,000
28,599
21
2,138
22
2,924
2,312
2,673
29
26
25,694
20
21
20
20
28,656
28,656
28,599
289,876
20,468
206
206
206
299,005
22
24
24
29,143
28,558
22,393
24
206
29.1
28.7
25
258,000
201,000
207,000
203,000
2,138
22
2,138
26
28
28
206
25,694
26
2,623
25
25
2,040
2,593
2,624
2.3
29.0
2.9
2,900
2,900
22,000
26,800
2,319
2,412
2,627
224
2,740
2,412
281
272
24
2.4
2.3
2.3
230,000,000
28,599,285
2.9164
2.9163
2.95
279,000
2.948
2.97
2.05
2.05
2.05
2.05
29.1
28.7
2,560,000
20
2.99
279
27
2,213
20,000
2.63
200,000
2.87
200.0
2.03
2
207
240
261,032
249,204
286,585
286,585
2,274,709
200,014
2,850,000
21,162
2.9164
2.9163
2.95
2,420,000
2,000,000
2.97
29.1
2.05
2,569,000
2,052,026
200,000
25,000
2,138
22
2,138
2,816
247
29
2,138
22
2,138
We found 109 numbers that start with the digit 3. Here they are:
31,029
36
3,540
36,263
3,567
35,081
38,385
37,711
367,387
338,244
357,210
350,539
35,081
3,115
3,312
338,244
350,539
367,387
357,210
310,295
36
36
310,553
313
3,312
323
30
3,830
307
307
3,854
32,729
357.2
31.0
32.7
3,188,181
30
3.6
36,000
37
39,000
3,000
31,000
31
3,372
35,346
36,194
360
340
313,000
35.1
3.5
36,850
37,955
381
366
328
384,477
30.60
342,888
3.0
3.05
367,000
3,461,138
37,037
3,069,926
3,609,755
36,000
30.60
342,888
3,069,926
366
33.80
356,045
3.18
3.18
34.95
37.47
3.05
330,000
3.34
3.18
3.05
3.93
38
3.8
30.60
300,187
300,187
39,154
37,380
33,150
342,888
342,889
342,888
3,499,998
33,898
37,037
3,878,000
310,835
33,670
3,069,926
3,000,000
3,500,000
3,028
38
375
335
3,312
4's 5's 6's
We found 59 numbers that start with the digit 4. Here they are:
459
410
4,566
418
433
47,355
41
45
473
473
41
49
418
418
40
484
473
418
46
49
487
487,000
40,174
43,546
4,506
484,000
440
440
440
433
4
43.7
4,826
487
420
433
4.9
4,818
42,373
4.99
4.99
487,000
412
4,928
446
4.15
4.10
4.81
42
473
418
472,354
42,373
456
4,956
491
473
418
45
We found 40 numbers that start with the digit 5. Here they are:
50,142
5,000
5
5,126
5
5,332
5,858
5.0
515
5
5
5,980
50
50
5
5,323
5,984
5.0
50
506
554
5,000,000
51
51
5.4
570,000
5,000,000
5,076,900
538,000
5.4
5
50
50
5,882
5,076,900
5,165,695
5,033
5,108
5,543
511
We found 38 numbers that start with the digit 6. Here they are:
642
691
60,360
60,360
6,799
6,671
6,671
6,671
6,671
6,651
6,671
6,671
6,671
65
62
61,000
62
6,671
6,671
6,000
60
6,795
6,324
6.8
61,640
60,714.29
695
6
610,622
656
6.03
638,000
693
65
6,799
6,671
611
6,324
7's 8's 9's
We found 33 numbers that start with the digit 7. Here they are:
7,275
7
7
7,278
751
7.3
70
70
77,000
70,000
756
761
773
770
7,433
7,705
7,155
7,000
75,844
78,188
705
7.5
7,536,706
760,866
756
75.0
7.08
7,057,688
73,169
70,000
716,000
786
7,155
We found 27 numbers that start with the digit 8. Here they are:
8,636
821
806
846
879
8,124
8,264
8,261
8,273
879
854
89
836,000
88
88
8,264
848,000
848
8,366
80,534
8,362
863
850
8
836,000
8,093,362
879
We found 47 numbers that start with the digit 9. Here they are:
9,683
9,312
9,267
9,129
9,129
9,335
9,129
9
9,138
9,129
9,129
9
9
9,129
96
98
9.4
99
97
91,000
9,129
9,335
9,722
946
914
947
968
926
935
9.87
97
926
98
92,000
9.99
9.4
9.99
97.00
91.0
90.0
916,000
97,561
99,000
9.99
92
9,267
9,129
While the above OCX 10Q Filed 5/12/2025 is interesting in isolation, we have found that it is also useful to take a look at older Oncocyte Corp filings processed by our Benford's Law Stocks algorithm, to see how the company's filings "typically look" on a Benford's Law analysis. Below we repeat the 10Q Filed 5/12/2025 but instead of the chart comparing against the typical company across our coverage universe, below we show the same chart compared against the typical OCX 10Q and 10K filings that we have processed historically. This is followed by similar charts for each of those historical filings.

28.3
20.5
15.8
8.6
5.8
5.5
4.8
3.9
6.8
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 73
XBRL?   [ original filing ]
Total numbers found: 689

= Typical OCX range from 4/15/2024 to 5/12/2025
29.0
16.2
11.5
12.9
12.9
3.2
4.9
6.7
2.7
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 49
XBRL?   [ original filing ]
Total numbers found: 878

= Typical OCX range from 4/15/2024 to 5/12/2025
30.0
20.2
12.0
9.9
8.7
6.3
4.6
4.4
3.9
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 99
XBRL?   [ original filing ]
Total numbers found: 917

= Typical OCX range from 4/15/2024 to 5/12/2025
24.8
18.7
11.9
11.0
13.0
5.1
4.3
5.4
5.7
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 68
XBRL?   [ original filing ]
Total numbers found: 646

= Typical OCX range from 4/15/2024 to 5/12/2025
30.0
17.5
12.3
8.5
9.0
7.3
5.5
4.8
5.1
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 93
XBRL?   [ original filing ]
Total numbers found: 924

= Typical OCX range from 4/15/2024 to 5/12/2025
28.1
18.9
13.0
10.0
11.2
5.3
4.7
4.4
4.4
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 94
XBRL?   [ original filing ]
Total numbers found: 793

= Typical OCX range from 4/15/2024 to 5/12/2025
 

Benford's Law OCX Stock (Oncocyte Corp) | www.Benford'sLawStocks.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in BenfordsLawStocks.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.